Related references
Note: Only part of the references are listed.Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia
Bei Jia et al.
CANCER RESEARCH (2019)
The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells
Alice Gutjahr et al.
JCI INSIGHT (2019)
High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells
Jing Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Harnessing the Induction of CD8+ T-Cell Responses Through Metabolic Regulation by Pathogen-Recognition-Receptor Triggering in Antigen Presenting Cells
Francesco Nicoli et al.
FRONTIERS IN IMMUNOLOGY (2018)
Naive CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells
Francesco Nicoli et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses
Alice Gutjahr et al.
JOURNAL OF IMMUNOLOGY (2017)
Immunological considerations regarding parental concerns on pediatric immunizations
Francesco Nicoli et al.
VACCINE (2017)
Preclinical and clinical development of neoantigen vaccines
L. Li et al.
ANNALS OF ONCOLOGY (2017)
Priming of Qualitatively Superior Human Effector CD8+ T Cells Using TLR8 Ligand Combined with FLT3 Ligand
Anna Lissina et al.
JOURNAL OF IMMUNOLOGY (2016)
Triggering Intracellular Receotors for Vaccine Acjuvantation
Alice Gutjahr et al.
TRENDS IN IMMUNOLOGY (2016)
TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
Burcu Temizoz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Differential Adjuvant Activities of TLR7 and TLR9 Agonists Inversely Correlate with Nitric Oxide and PGE2 Production
Jinhee Lee et al.
PLOS ONE (2015)
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway
Claudia Volpi et al.
NATURE COMMUNICATIONS (2013)
Type 1 Interferons and Antiviral CD8 T-Cell Responses
Raymond M. Welsh et al.
PLOS PATHOGENS (2012)
Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9
Peter Allacher et al.
BLOOD (2011)
acDCs enhance human antigen-specific T-cell responses
Emanuela Martinuzzi et al.
BLOOD (2011)
Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides
George Mutwiri et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus
Sean R. Christensen et al.
IMMUNITY (2006)
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site
Victor Appay et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-1β, but not IL-1α, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses
A Nambu et al.
INTERNATIONAL IMMUNOLOGY (2006)
Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO
G Wingender et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Avidity for antigen shapes clonal dominance in CD8+T cell populations specific for persistent DNA viruses
DA Price et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cutting edge:: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2005)
Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration
M Heikenwalder et al.
NATURE MEDICINE (2004)
IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences
O Duramad et al.
BLOOD (2003)
Share Paper
